Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
Over the past 50 years, breast cancer immunotherapy has emerged as an active field of research, generating novel, targeted treatments for the disease. Immunotherapies carry enormous potential to improve survival in breast cancer, particularly for the subtypes carrying the poorest prognoses. Here, we...
Enregistré dans:
Auteurs principaux: | Chiara Cilibrasi, Panagiotis Papanastasopoulos, Mark Samuels, Georgios Giamas |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b3b25a1781634d50a5f35e21acee8ac2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
par: Silvia Jiménez-Morales, et autres
Publié: (2021) -
Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
par: Xupeng Bai, et autres
Publié: (2021) -
Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
par: Alessandro Allegra, et autres
Publié: (2021) -
Histamine in cancer immunology and immunotherapy. Current status and new perspectives
par: María de la Paz Sarasola, et autres
Publié: (2021) -
Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists
par: Raveena Nagareddy, et autres
Publié: (2021)